Hairy Cell Leukemia

Oncology
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)N/A
I
IQVIANC - Durham
1 program
US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)N/A1 trial
Active Trials
NCT04125290Terminated2Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IQVIAUS Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Clinical Trials (1)

Total enrollment: 2 patients across 1 trials

NCT04125290IQVIAUS Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Start: Dec 2019Est. completion: Jun 20212 patients
N/ATerminated

Related Jobs in Oncology

Summer intern Neuroscience

Arvinas
New Haven - CT
8h ago

Medical Representative - CVRM - HCM

AstraZeneca
Vietnam - Ho Chi Minh City
12h ago

Operator

Sartorius Stedim Biotech
Shanghai
12h ago

Technician, Quality Assurance - Night Shift

Orca Bio
Sacramento, CA
13h ago
$65K - $71K/yr

Supervisor, Materials and Cold Chain Operations - Night Shift

Orca Bio
Sacramento, CA
18h ago
$75K - $95K/yr

Supervisor, Materials and Cold Chain Operations - Day Shift

Orca Bio
Sacramento, CA
18h ago
$75K - $95K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(582)Prostate Cancer(389)Non-small Cell Lung Cancer(388)Multiple Myeloma(362)Cancer(251)Advanced Solid Tumors(229)Acute Myeloid Leukemia(210)Neoplasms(203)Colorectal Cancer(172)Melanoma(170)